These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17659766)

  • 1. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.
    Chan WS; Dixon ME
    Thromb Res; 2008; 121(6):713-26. PubMed ID: 17659766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology.
    Chan WS
    Curr Opin Obstet Gynecol; 2009 Jun; 21(3):207-18. PubMed ID: 19276806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombotic risk in assisted reproductive technology].
    Alatri A; Tribout B; Gencer B; Calanca L; Mazzolai L
    Rev Med Suisse; 2011 Feb; 7(281):357-60. PubMed ID: 21416715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombosis and assisted reproductive techniques (ART)].
    Conard J; Plu-Bureau G; Horellou MH; Samama MM; Gompel A
    J Mal Vasc; 2011 Jun; 36(3):145-54. PubMed ID: 21333476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome and thrombotic events.
    Mor YS; Schenker JG
    Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome and complications of ART.
    Vloeberghs V; Peeraer K; Pexsters A; D'Hooghe T
    Best Pract Res Clin Obstet Gynaecol; 2009 Oct; 23(5):691-709. PubMed ID: 19632900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report.
    Rao AK; Chitkara U; Milki AA
    Hum Reprod; 2005 Dec; 20(12):3307-12. PubMed ID: 16085662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the complications associated with assisted reproductive technologies.
    Patchava S; Gelbaya TA; Nardo LG
    Minerva Ginecol; 2009 Aug; 61(4):347-55. PubMed ID: 19745799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined jugular and subclavian vein thrombosis following assisted reproductive technology--new observation.
    Salomon O; Schiby G; Heiman Z; Avivi K; Sigal C; Levran D; Dor J; Itzchak Y
    Fertil Steril; 2009 Aug; 92(2):620-5. PubMed ID: 18710711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of superovulation and ART procedures.
    Weinerman R; Grifo J
    Semin Reprod Med; 2012 Apr; 30(2):77-83. PubMed ID: 22549707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of ovarian hyperstimulation syndrome.
    Vlahos NF; Gregoriou O
    Ann N Y Acad Sci; 2006 Dec; 1092():247-64. PubMed ID: 17308149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes from assisted reproductive technology.
    Van Voorhis BJ
    Obstet Gynecol; 2006 Jan; 107(1):183-200. PubMed ID: 16394060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
    Mathur R; Kailasam C; Jenkins J
    Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome.
    Jóźwik M
    Med Wieku Rozwoj; 2012; 16(4):269-71. PubMed ID: 23378404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Upper extremity deep vein thrombosis following ovarian stimulation].
    Bar-On S; Cohen A; Levin I; Avni A; Lessing JB; Atmog B
    Harefuah; 2011 Nov; 150(11):849-51, 875. PubMed ID: 22428206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive care for ovarian hyperstimulation syndrome].
    Shifman EM; Pogodin OK; Gumeniuk EG; Pogodin OO
    Anesteziol Reanimatol; 2007; (4):77-81. PubMed ID: 17929495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)?
    Ajonuma LC
    Med Hypotheses; 2008; 70(6):1174-8. PubMed ID: 18164141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future developments to minimize ART risks.
    Marzal A; Holzer H; Tulandi T
    Semin Reprod Med; 2012 Apr; 30(2):152-60. PubMed ID: 22549715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.